Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Dreavent Capital is a venture fund based in Boston, Massachusetts, that has been operational for over 14 years. The firm focuses on investing in the biotech sector, particularly in emerging U.S. biopharma companies. Dreavent aims to convert scientific research into innovative patient treatments, emphasizing the importance of advancing healthcare through biotechnology.
As of now, Dreavent Capital has made several investments in notable biotech firms, demonstrating its active engagement in the sector. The firm targets various stages of investment, including seed, Series A, Series B, and growth equity, allowing it to support companies at different points in their development. While specific details regarding assets under management (AUM) or team size are not disclosed, Dreavent's commitment to the biotech industry is evident through its ongoing support of innovative companies.
Dreavent Capital invests primarily in biotech firms that specialize in oncology, neurology, cardiovascular & metabolic, and immunology. The firm identifies sectors that are ripe for innovation and investment returns, with a particular emphasis on immunology due to its potential for developing new therapies. This focus aligns with Dreavent's mission to convert scientific research into effective patient treatments.
The firm seeks to partner with companies that demonstrate strong scientific foundations and innovative approaches to healthcare challenges. Dreavent's investment strategy encompasses various stages, allowing it to engage with startups and established firms alike. The firm is particularly interested in companies that can deliver significant advancements in patient care through their research and development efforts.
Dreavent Capital has invested in several notable companies within the biotech sector, showcasing its commitment to supporting innovative solutions in healthcare. The portfolio includes:
This diverse portfolio reflects Dreavent's strategic focus on companies that are at the forefront of biopharmaceutical innovation.
To pitch Dreavent Capital, founders should visit their website at dreaventcapital.com. It is recommended to include a comprehensive overview of the company's scientific research, market potential, and how the proposed solution addresses a significant healthcare challenge.
What are Dreavent Capital's investment criteria?
Dreavent Capital focuses on biotech firms specializing in oncology, neurology, cardiovascular & metabolic, and immunology. The firm seeks companies with strong scientific foundations and innovative approaches to healthcare.
How can I apply or pitch to Dreavent Capital?
Founders can pitch to Dreavent Capital through their website at dreaventcapital.com. It is advisable to include detailed information about the company's scientific research and potential impact on patient care in the pitch.
What makes Dreavent Capital different from other investors?
Dreavent Capital emphasizes investments in sectors that are ripe for innovation, particularly in immunology, which has significant potential for developing new therapies. This focus allows them to identify high-impact opportunities in the biotech space.
What is the geographic scope of Dreavent Capital's investments?
The firm primarily invests in emerging U.S. biopharma companies, focusing on the North American market.
What is Dreavent Capital's post-investment involvement like?
Dreavent Capital actively supports its portfolio companies, providing resources and guidance to help them navigate the complexities of the biotech industry.
What is the typical check size for investments made by Dreavent Capital?
While specific check sizes are not disclosed, Dreavent invests at various stages, including seed, Series A, Series B, and growth equity, indicating a flexible approach to funding.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.